Recently, next generation sequencing methods for the mutation analysis of the BRCA1 and BRCA2 genes in patients with breast and ovarian cancer have been described using both high capacity and bench top platforms [13–18]. The gene discussed is BRCA2; the disease is ovarian cancer.